Akash Balki

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Shree Krishna Hospital(Current)

Glenmark Pharmaceuticals (India)

Akash Balki is an author at Shree Krishna Hospital specializing in clinical pharmacology, chronic obstructive pulmonary disease pharmacotherapy, and long-acting muscarinic antagonist combinations.

Publications per year

2021–2024

Publications

Expert panel opinion on adult pneumococcal vaccination in the post-COVID era (NAP- EXPO Recommendations-2024)

Parvaiz A Koul, Agam C. Vora, Surinder K. Jindal et al. · Lung India · 2024 · 14 citations · Full text

Medicine, Infectious Diseases, Preventive Medicine +17

Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial

Sundeep Salvi, Akash Balki, Srikanth V. Krishnamurthy et al. · ERJ Open Research · 2021 · 13 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Evaluation of the Safety and Efficacy of Favipiravir in Adult Indian Patients with Mild-to-Moderate COVID-19 in a Real-World Setting

Pavan Kumar Reddy, Saiprasad Patil, Akash Khobragade et al. · International Journal of General Medicine · 2022 · 10 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

1–3 of 3